QNME

QNME(QNME)股票分析

$0.331

+0.007 (+2.01%)收盤時

Loading chart…
High
0.341
Open
0.322
VWAP
0.33
Vol
36.25K
Mkt Cap
Low
0.320
Amount
11.98K
EV/EBITDA, TTM
0.00

Lakeside Holding Limited is a holding company. The Company, through its subsidiary, Hupan Pharmaceutical (Hubei) Co., Ltd, is a medical injection and pharmaceutical distributor. It procures products from manufacturers, stores the products at designated warehouses, and distributes them to hospitals, distributors and other healthcare providers, primarily through agents.

AI analysis of QNME (QNME)

sell

Given the current price of 0.33 USD and a significant decline of 31.12% over the last 20 days, this asset is not a good buy right now. The forward P/E is 0, indicating no earnings growth expectations, and the gross margin is only 26.83%, which is relatively low for a healthy company. Additionally, the negative net income of -1583681 USD in the latest quarter raises concerns about profitability.

估值指標

The current forward P/E ratio for QNME (QNME) is 0.00, compared to its 5-year average forward P/E of .

Forward P/E

5Y Average P/E
Current P/E
0.00

Forward EV/EBITDA

5Y Average EV/EBITDA
Current EV/EBITDA
0.00

Forward P/S

5Y Average P/S
Current P/S
0.00

QNME FAQ — answered by Alphio AI

Given the current price of 0.33 USD and a significant decline of 31.12% over the last 20 days, this asset is not a good buy right now. The forward P/E is 0, indicating no earnings growth expectations, and the gross margin is only 26.83%, which is relatively low for a healthy company. Additionally, the negative net income of -1583681 USD in the latest quarter raises concerns about profitability.

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

免費開始